Monotherapy of experimental metabolic syndrome: I. Efficacy and safety
, , , , , e
14 feb 2018
INFORMAZIONI SU QUESTO ARTICOLO
Pubblicato online: 14 feb 2018
Pagine: 81 - 85
Ricevuto: 12 set 2017
Accettato: 15 ott 2017
DOI: https://doi.org/10.1515/intox-2017-0013
Parole chiave
© 2017 Interdisciplinary Toxicology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.
Bezek, Štefan
Institute of Experimental Pharmacology and Toxicology, Slovak Academy of SciencesBratislava, Slovakia
Brnoliaková, Zuzana
Institute of Experimental Pharmacology and Toxicology, Slovak Academy of SciencesBratislava, Slovakia
Sotníková, Ružena
Institute of Experimental Pharmacology and Toxicology, Slovak Academy of SciencesBratislava, Slovakia
Knezl, Vladimír
Institute of Experimental Pharmacology and Toxicology, Slovak Academy of SciencesBratislava, Slovakia
Paulovičová, Ema
Institute of Chemistry, Slovak Academy of SciencesBratislava, Slovakia
Navarová, Jana
Institute of Experimental Pharmacology and Toxicology, Slovak Academy of SciencesBratislava, Slovakia
Bauer, Viktor
Institute of Experimental Pharmacology and Toxicology, Slovak Academy of SciencesBratislava, Slovakia